Bonum Certa Men Certa

What Happened in the United States Now Happens in Europe: Lots of Patents Turn Out to Be Bunk, Fake, Bogus, Invalid and Thus Worthless

Low patent quality has done incredible harm/damage to confidence in the system

Cardboard recycling



Summary: Worthless patents -- not opposition to such patents -- are the greatest threat to the legitimacy of the patent system, yet bureaucrats fail to heed the warning in the name of short-term profits

HERE AT TECHRIGHTS we've been following the U.S. Patent and Trademark Office (USPTO) for more than a decade and a half (I wrote about it long before the site even existed). When I was about 20 I was upset to see Graffiti input on Palm being destroyed by patents. I wrote about it in my personal blog. Such ridiculous US patents could possibly be used by a relic like Xerox to embargo -- e.g. via ITC -- devices I so often used (I still own and use a Palm PDA). The workaround was known as Graffiti 2, which is vastly inferior. The PDA I use was manufactured in 2003 -- the same year Graffiti 2 was introduced, so I'm lucky to have dodged this sabotage by patents. For those who wonder what got me upset at such patents (software patents), that was it. Richard Stallman often attributes the creation of GNU and then the FSF to Xerox printers that upset him. So I share more than my initials with him and we've been good friends. We share our views on patents and the European patent system.



Things have changed a lot since, especially in 2014 when SCOTUS ruled on Alice, giving rise to 35 U.S.C. ۤ 101 as we now know it.

"We are saddened to see Europe falling into the same trap that the US had fallen into a few decades ago when the Federal Circuit gave a green light to software patents."Seeing what happens in the US this year, we're not even tempted to resume coverage of it. Virtually all cases are concluded the way we'd like them to. Janal Kalis ("Patent Buddy") is still obsessing over mere patent applications, as PTAB and district courts have nothing for these patent maximalists to celebrate. This week he wrote: “The PTAB Reversed an Examiner’s 101 Rejection of Claims for a Method of Detecting Similar Objects” (the exception).

Usually it's the other way around. We also note that patent extremists blame "big tech" for the demise of software patents, never mind if "small tech" (firms) too pushed towards that. "They ‘happen’ to be those who also produce a lot of software," I replied to him, "unlike patent trolls and law firms, so…"

"It is impossible to argue (any longer) that the EPO has no patent quality issues; even the EPO's management now admits it."Readers can probably agree that what happened in the US after Alice, more so in recent years as caselaw shaped up, was overwhelmingly positive. Developers were able to focus on actual work rather than hire lawyers.

We are saddened to see Europe falling into the same trap that the US had fallen into a few decades ago when the Federal Circuit gave a green light to software patents. The European Patent Office (EPO) under the leadership of António Campinos is a very vocal booster of software patents in Europe. The managers at the Office, preoccupied and obsessed with so-called 'production', are still trying very hard to break the rules (e.g. misinterpret the EPC) and grant bogus patents -- European Patents courts would reject such as "blockchain" patents.

The EPO has already admitted these are software patents as so does Bastian Best on Twitter, soon to be retweeted by EPO (official). The EPO reposted this yesterday: "For the blockchain enthusiasts in my network: Koen Lievens does a great job in this video explaining how #blockchain inventions can be #patent’ed at the @EPOorg. Hint: It’s the exact same standard as for any other type of CII."

What are these people thinking? Bearing in mind the EPO's own admission of quality problems (albeit internally only, for now), shouldn't they quit this madness? Sooner or later all these patents will fall in an avalanche like Alice in the US.

Meanwhile, judging by yesterday's long post from IP Kat, the non-impartial and not-so-independent (i.e. partially dependent) EPO appeal boards are hard to rely on as long as Battistelli and Campinos, two crooked patent maximalists, control them. Watch this latest situation:

A recent decision by the EPO Technical Boards of Appeal (TBA) departed from previous boards on how the novelty of the increased purity of a known compound is to be assessed. In T 1085/13, the TBA diverged from previous decisions that established special criteria for determining the novelty of a claim directed to a known compound of increased purity. The decision also ignores the criteria set out in the EPO Guidelines for Examination. These state that to be novel a selection invention must be “purposive”. The decision therefore confirms that the EPO is prepared to depart from its previous positions on the criteria for assessing the novelty of selection inventions. It seems that, for the purpose of assessing novelty, the TBA are now in favour of applying the same novelty criteria to these inventions as to any other type of invention, and nothing further.

[...]

As far as this Kat is aware, T 1085/13 is the first decision by the TBA to depart from the “special criteria” for purity inventions provided in T 0990/96 (although she is happy to be corrected on this if readers are aware of any earlier decisions).

T 1085/13 also appears to have ignored the criteria for selection inventions established by earlier TBA (and outlined in the EPO guidelines for examination) that a claimed selection must constitute a "purposive selection". This is in line with other recent decisions of the TBA. It therefore appears that the third criteria for the novelty of selection inventions is being phased out, although this is still not reflected in the most recent EPO Guidelines for Examination. If this really is to be the new position of the EPO, is it not time for these changes to be reflected in the guidelines? This Kat also awaits with interest to see whether this latest decision on purity inventions will be followed by subsequent boards and the Examiners.


Guidelines should be based on law, not so-called 'production' aspirations. This is akin to what Iancu does at the USPTO, in effect mimicking Battistelli. Judges are being pressured and condemned.

As further evidence of the decline of quality of patents (EPO and USPTO in this case), watch these two new reports (from yesterday) [1, 2] as they cover something we wrote about some days ago (based on the original press release). The gist of it is, the EPO admits it granted false patents... yet again (not just the USPTO, where such invalidation is a lot more common with Patent Trial and Appeal Board (PTAB) inter partes reviews (IPRs)).

To quote the first report:

The European Patent Office (EPO) and the US Patent and Trademark Office (USPTO) have both invalidated patents owned by Immunex Corporation. The patents cover antibodies that target human interleukin-4 receptors.

Regeneron Pharmaceuticals had opposed the patents, arguing that European patent 2,990,420 and US patent 8,679,487 were invalid due to the insufficiency of disclosure.

The EPO invalidated Immunex’s European patent a day after the USPTO’s Patent Trial and Appeal Board invalidated all 17 claims of the US patent due to obviousness.

Joseph LaRosa, executive vice president of Regeneron, commented: "We applaud decisions by the US and European patent offices this week, which invalidate Immunex's functional patent claims to antibodies that target human IL-4 receptors."


The second such report says:

Regeneron Pharmaceuticals (Nasdaq: REGN) has announced two important legal developments invalidating Immunex patents with functional claims to antibodies that target human interleukin-4 receptors (IL-4R).

On Friday, the Opposition Division of the European Patent Office (EPO) revoked wholly-owned by Amgen (Nasdaq: AMGN) subsidiary Immunex' European Patent No 2,990,420 in its entirety because the claims were invalid for insufficiency of disclosure. This follows a decision by the Patent Trial and Appeal Board (PTAB) of the US Patent & Trademark Office (USPTO) to invalidate all 17 claims of Immunex' US Patent No 8,679,487 as obvious. These decisions are subject to appeal by Immunex.

Regeneron’s shares closed up 2.17% at $423.79 on Friday, while Amgen dipped 1.51% to $185.50 in after-hours trading.

"We applaud decisions by the US and European patent offices this week, which invalidate Immunex' functional patent claims to antibodies that target human IL-4 receptors," said Joseph LaRosa, executive vice president, general counsel and secretary, at Regeneron. "It is our position that Immunex' functional claims unfairly attempt to claim ownership far beyond the molecules developed, and stifle innovation within the broader scientific community," he added.


It is impossible to argue (any longer) that the EPO has no patent quality issues; even the EPO's management now admits it.

Recent Techrights' Posts

WIPO UDRP D2024-0770 Debian vendetta response
Reprinted with permission from Daniel Pocock
Links 12/04/2024: Reporters Without Borders Rep Kicked Out of Hong Kong
Links for the day
Gemini Links 12/04/2024: Funny Thing, Manual Scripts, and More
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Thursday, April 11, 2024
IRC logs for Thursday, April 11, 2024
[Video] Trainline Finally Issues a Refund, But It Took 9 Days and Showed How 'Modern' Systems Fail Travelers
They treat people like a bunch of animals or cattle, not like valuable customers
DebConf22 Kosovo segregation of women exposed
Reprinted with permission from disguised.work
Links 11/04/2024: Web Diversity and More Crackdowns in Russia
Links for the day
Gemini Links 11/04/2024: Activity and Motivation in Geminispace, gwit Implementations
Links for the day
First They Came for Iranian Developers...
Red Hat/IBM and 'cancel culture'
[Video] A Debian Project Leader Needs to Also be a Technical Project Leader
We do not vouch for one (or none) horse in this race
Aggressive Efforts (and Threats) for Those Who Speak About What Happened in the Balkans
Acting in this way in an effort to censor people typically results in a second scandal on top of the original scandal
How Kosovo won DebConf21
Reprinted with permission from Daniel Pocock
[Video] How the Media Blamed SSH and Linux (for Nearly a Whole Fortnight!) Instead of Microsoft's GitHub and Systemd
Microsoft-connected sites have said a whole bunch of lies
Anzacathon: a hackathon for Anzac day at home
Reprinted with permission from Daniel Pocock
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Wednesday, April 10, 2024
IRC logs for Wednesday, April 10, 2024
On Julian Assange, Now 5 Years in Belmarsh Prison: The Good News, the Bad News, and Ugly Noise
Some time this spring (or summer) we'll revisit the Appelbaum case
Links 10/04/2024: Starvation as Weapon in Sudan, Sonos v. ITC Explained
Links for the day
Gemini Links 10/04/2024: JSON explore and geminiprotocol.net Downtime
Links for the day
Links 09/04/2024: Netflix Layoffs and Cox Will Try to Bring Copyright Liability of ISPs to SCOTUS
Links for the day
Links 10/04/2024: Biden Reportedly Considers Dropping the Charges Against Julian Assange
Links for the day
Wikileaks, Dickileaks & Ubuntu Underage girl
Reprinted with permission from the Free Software Fellowship
Gemini Links 10/04/2024: Tanana River, Picotron, and Citation on Gemini
Links for the day
Elio Qoshi & Redon Skikuli missing from OSCAL agenda
Reprinted with permission from the Free Software Fellowship
Links 10/04/2024: TikTok Trouble, East Asian Companies Receive Subsidies From American Taxpayers
Links for the day
This is What Techrights Would Look Like If We Participated in 'CSS Naked Day'
All cascading style sheets (CSS) should be optional
Microsoft Hiring People Who Attempt to Murder Colleagues
magnet for sociopaths
Francophone GNU/Linux
Moving in a positive direction
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Tuesday, April 09, 2024
IRC logs for Tuesday, April 09, 2024
Over-Enforcement of a Code of Conduct (CoC) Would Ruin Events, Maybe Not for Corporate Posters, Sponsors, Posers, and Speakers
a shrine for corporate supremacy
The "F" in Free Software Doesn't Stand for "Censorship"; Attempts to Censor Mere Links to Articles About DebConf22 in Kosovo
It's about an article we'll reproduce here later this week
Daniele Scasciafratte & Mozilla, OSCAL, Albania dating
Reprinted with permission from the Free Software Fellowship
Gemini Links 10/04/2024: Notifications, Motivation, Profectus Graphical Browser for the Smallnet
Links for the day
Abuse & Sex Crimes at FOSDEM and Open Source tech events
Reprinted with permission from the Free Software Fellowship